What should be the primary target of "treat to target" in psoriatic arthritis?

What should be the primary target of "treat to target" in psoriatic arthritis?

<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...

Podrobná bibliografie
Hlavní autoři:	Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS
Médium:	Journal article
Jazyk:	English
Vydáno:	Journal of Rheumatology 2018

Podobné jednotky

What should be the primary target of ‘treat to target’ in PsA?
Autor: Coates, L, a další
Vydáno: (2018)

Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
Autor: Coates, L, a další
Vydáno: (2022)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
Autor: Coates, L, a další
Vydáno: (2019)

Sustained very low disease activity and remission in psoriatic arthritis patients
Autor: Lubrano, E, a další
Vydáno: (2019)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
Autor: Lubrano E, a další
Vydáno: (2016-10-01)

New approved drugs for psoriatic arthritis
Autor: F.M. Perrotta, a další
Vydáno: (2016-09-01)

Precision medicine in psoriatic arthritis: how should we select targeted therapies?
Autor: Al-Mossawi, H, a další
Vydáno: (2019)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
Autor: Ennio Lubrano, a další
Vydáno: (2019-08-01)

How should we define disease and outcomes in axial psoriatic arthritis?
Autor: Coates, LC
Vydáno: (2021)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Autor: Ennio Lubrano, a další
Vydáno: (2023-07-01)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
Autor: P.S. Helliwell
Vydáno: (2011-09-01)

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.
Autor: Coates, L, a další
Vydáno: (2017)

Does treat to target or achieving remission improve radiographic outcome in psa?
Autor: Coates, L, a další
Vydáno: (2016)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
Autor: Weinstein, SM, a další
Vydáno: (2021)

Novel concepts in psoriatic arthritis management: Can we treat to target?
Autor: Tucker, L, a další
Vydáno: (2018)

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
Autor: Dures, E, a další
Vydáno: (2020)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
Autor: Ye, W, a další
Vydáno: (2021)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
Autor: Gladman, DD, a další
Vydáno: (2022)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
Autor: Helliwell, PS, a další
Vydáno: (2023)

Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST Study
Autor: Perrotta, FM, a další
Vydáno: (2024)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
Autor: Ye, W, a další
Vydáno: (2021)

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
Autor: F.M. Perrotta, a další
Vydáno: (2019-07-01)

Current concepts and unmet needs in psoriatic arthritis
Autor: Mahmood, F, a další
Vydáno: (2017)

Psoriatic arthritis: prospects for the future
Autor: Hackett, S, a další
Vydáno: (2022)

Should methotrexate have any place in the treatment of psoriatic arthritis?
Autor: Ye, W, a další
Vydáno: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
Autor: Helliwell, PS, a další
Vydáno: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Autor: Coates, L, a další
Vydáno: (2016)

Measuring outcomes in psoriatic arthritis
Autor: Ogdie, A, a další
Vydáno: (2020)

Outcome measures in psoriatic arthritis: where next?
Autor: Hackett, S, a další
Vydáno: (2022)

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
Autor: Ennio Lubrano, a další
Vydáno: (2022-12-01)

Psoriatic arthritis: lessons from imaging studies and implications for therapy
Autor: Mathew, A, a další
Vydáno: (2016)

Assessing disease activity in psoriatic arthritis: a literature review
Autor: Tucker, L, a další
Vydáno: (2018)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
Autor: Mease, PJ, a další
Vydáno: (2020)

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
Autor: Helliwell, P, a další
Vydáno: (2019)

Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial
Autor: O'Dwyer, J, a další
Vydáno: (2018)

Remission in psoriatic arthritis—where are we now?
Autor: Coates, L, a další
Vydáno: (2017)

Identification of psoriatic arthritis in patients with psoriasis
Autor: Coates, LC, a další
Vydáno: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
Autor: Soriano, ER, a další
Vydáno: (2023)

Psoriatic arthritis: imaging techniques
Autor: E. Lubrano, a další
Vydáno: (2012-06-01)

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
Autor: Coates, L, a další
Vydáno: (2018)